Background. Early diagnosis of pancreatic steatosis is essential for the early metabolic risk detection and chronic gastroenterological morbidity reduction. The purpose was to examine the clinical and sonographic features of pancreatic steatosis in children with overweight and obesity. Materials and methods. The presence of pancreatic steatosis was determined by ultrasonography in 53 children with functional disorders of the gastrointestinal tract. Division in groups was performed on the basis of pancreatic steatosis and obesity/overweight presence: group 1 consisted of 24 patients with pancreatic steatosis and obesity/overweight, group 2 included 18 children with obesity/overweight with no signs of pancreatic steatosis, the control group consisted of 11 patients without pancreatic steatosis and with normal weight. Results. The clinical picture in children with pancreatic steatosis may be explained by concomitant gastroenterological diseases, but 29.1 % of group 1 patients complained of pain in the left upper quadrant. Patients with steatosis often complained of nausea (58.3 %), flatulence (45.8 %) in comparison to patients who had normal weight, but the significance of the differences was not sufficient. Group 1 patients often reported pain on palpation of the intestine compared with other 2 groups. Pain on palpation in pancreatic points was significantly higher in group 1 patients (54.1 %) compared to group 3. Increased liver echogenicity was found 2.4 times more often in group 1 patients compared with group 2. In particular, changes in liver grains were three times more common in patients with steatosis (p < 0.05), as compared to the obese patients without steatosis and to the children with normal weight. Pancreatic changes in steatosis manifested not only by the changes in echogenicity, but also by fuzzy contours of the pancreas, increased grain (65.5 %) in almost half of patients (45.8 %). Gallbladder volume and wall thickness were significantly higher in the group of children with steatosis compared to the control group. Symptoms of biliary sludge were twice more common in children with steatosis compared to children without steatosis and 4 times more likely than in children with normal weight (43.87 % in group 1; 21 % in group 2, and 9 % in group 3). Conclusions. Thus, clinical and sonographic features in patients with steatosis indicate the possibility of inflammatory changes in the parenchyma associated with systemic inflammation due to steatosis and concomitant diseases of the gastrointestinal tract.
pancreatic steatosis; steatopancreatitis; children
Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci. 2013 Apr;1281:123-40. doi: 10.1111/nyas.12030.
Maiev IV, Kazyulin AN, Dicheva DT, Curly YA. Chronic pancreatitis: Textbook. Moskow: VUNMTS Ministry of Health; 2007. 80 p.
Catanzaro R, Cuffari B, Italia A, Marotta F. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroenterol. 2016 Sep 14;22(34):7660-75. doi: 10.3748/wjg.v22.i34.7660.
Samsonova NG, Zvenyhorodskaya LA. Clinical and functional state of pancreas in metabolic syndrome. Jeksperimental'naja i klinicheskaja gastrojenterologija. 2012;11:96-100. (In Russian).
Smereczyński A, Kołaczyk K. Is a fatty pancreas a banal lesion? J Ultrason. 2016 Sep;16(66):273-80. doi: 10.15557/JoU.2016.0027.
Makino N, Shirahata N, Honda T, et al . Pancreatic hyperechogenicity associated with hypoadiponectinemia and insulin resistance: A Japanese population study. World J Hepatol. 2016 Nov 28;8(33):1452-1458. doi:10.4254/wjh.v8.i33.1452.
de Oliveira Andrade LJ, Guimarães LR, Fernandes Cadete RB, et al. Pancreatic steatosis and its association with nonalcoholic fatty liver disease evaluated by ultrasonography. Brazilian Journal of Medicine and Human Health. 2015;3(2):37-43 doi: 10.17267/2317-3386bjmhh.v3i2.653.
Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15(15):1869-75. PMID: 19370785.
World Health Organization. BMI-for-age (5-19 years). Available from: http://www.who.int/growthref/who2007_bmi_for_age/en/
Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145(4):439-44. doi: 10.1016/j.jpeds.2004.06.044.
Targher G, Rossi AP, Zamboni GA, et al. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Invest. 2012 Sep;35(8):748-53. doi: 10.3275/8011.
Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2002;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001.
Kim HJ, Lim CW, Lee JH, et al. Gender-based differences in the relationship between fatty liver disease and atherosclerosis. Cardiovasc J Afr. 2016 Sep/Oct 23;27(5):281-286. doi: 10.5830/CVJA-2016-014.
Gastaldelli A, Gaggini M. Ectopic fat: a target for cardiometabolic risk management. Expert Rev Cardiovasc Ther. 2016 Dec;14(12):1301-1303. doi: 10.1080/14779072.2016.1256773.
Kim D, Kim WR. Nonobese Fatty Liver Disease. Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028.
van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014 Feb 1;14:9. doi: 10.1186/1472-6823-14-9.
Babinets LS, Kytsai KYu. Clinical and pathogenetic aspects of chronic pancreatitis of Biliary Genesis and Obesity. Hastroenterolohiya. 2016;59:86-92. (in Ukrainian).
Belousov YuV. Pancreatitis and pancreatopathy: classification characteristics, principles of diagnosis and treatment in children. Zdorov'ye Rebenka. 2012;43:129-133. (in Russian).
Zavgorodnyaya NYu, Lukianenko OYu. Clinical and laboratory features of the pancreatic steatosis in children with overweight and obesity. Hastroenterolohiya. 2017;51(1):22-27. (In Ukrainian).
Stepanov YM, Zaichenko NG. Chronic pancreatitis: biliary mechanisms factors and its course. Zaporozhye Medical Journal. 2012;70:46-50. (In Ukrainian).
Samsonova NG. Clinical and diagnostic features of steatosis of the pancreas in patients with the metabolic syndrome. Jeksperimental'naja i klinicheskaja gastrojenterologija. 2012;7:60-63. (in Russian).
Uygun A, Kadayifci A, Demirci H, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015 Jan;26(1):37-41. doi: 10.1016/j.ejim.2014.11.007.
Di Ciaula A, Wang DQ, Portincasa P. Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol. 2012;. 27(8):1298-1305. doi: 10.1111/j.1440—1746.2012.07149.x.
Bulgakov NP, Prokopenko OP, Golunov AI, Kolodyazhnaya NV. Ekhografiya bryushnoy polosti i zabryushinnogo prostranstva [Sonography of the abdomen and retroperitoneal space]. SPb.: Shipbuilding; 1996. 160 p. (In Russian).
Ministry of Health of Ukraine. Order of 29.01.2013 № 59: Unified clinical protocols of medical care for children with digestive diseases. Available from: https://medprosvita.com.ua/nakaz-moz-ukrayini-vid-29-01-2013-n-59-pro-zatverd/
Zvenigorodskaya LA, Khachaturyan NE. Functional, clinical and morphological transformations of the pancreas and metabolic syndrome. Consilium Medicum. 2016;18(8):51-58. (In Russian).